Galapagos’ service division, BioFocus DPI, has expanded and extended its drug discovery collaboration with Amgen through 2008. BioFocus DPI will continue to provide biology, computational and medicinal chemistry services and will supply biologically-directed library compounds to Amgen’s discovery programs. Under the terms of the extended agreement, Galapagos will receive an upfront payment of $2.4 million for 2007 research costs. Galapagos may also receive compensation in the form of...